<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang C</submitter><funding>Natural Science Foundation of Guangdong Province, China</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>103523</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7561017</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>95</volume><pubmed_abstract>It has been shown that inclusion of CF&lt;sub>3&lt;/sub>O and CHF&lt;sub>2&lt;/sub>O groups to drug candidates often improve their pharmacological properties, especially metabolic stability, membrane permeability and PK profile. Moreover, the unique non-spherical structure of the OCHF&lt;sub>2&lt;/sub> group can provide interesting and beneficial characteristics. Accordingly, new 3rd-generation taxoids, bearing 3-OCF&lt;sub>3&lt;/sub> or 3-OCF&lt;sub>2&lt;/sub>H (and 3-CH&lt;sub>3&lt;/sub> for comparison) at the C2 benzoate moiety, were synthesized and their potencies against drug-sensitive and drug-resistant cancer cell lines examined. In this study, our previous SAR studies on 3rd-generation taxoids were expanded to disclose that CH&lt;sub>3&lt;/sub>, CF&lt;sub>3&lt;/sub>O and CHF&lt;sub>2&lt;/sub>O groups are well tolerated at this positio</pubmed_abstract><journal>Bioorganic chemistry</journal><pubmed_title>Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH&lt;sub>3&lt;/sub>, 3-CF&lt;sub>3&lt;/sub>O and 3-CHF&lt;sub>2&lt;/sub>O groups at the C2-benzoate position.</pubmed_title><pmcid>PMC7561017</pmcid><funding_grant_id>CA 103314</funding_grant_id><funding_grant_id>2015B020211012</funding_grant_id><funding_grant_id>2016A050502039</funding_grant_id><funding_grant_id>R01 CA103314</funding_grant_id><pubmed_authors>Ojima I</pubmed_authors><pubmed_authors>Botchkina GI</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Yan S</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Taouil AK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH&lt;sub>3&lt;/sub>, 3-CF&lt;sub>3&lt;/sub>O and 3-CHF&lt;sub>2&lt;/sub>O groups at the C2-benzoate position.</name><description>It has been shown that inclusion of CF&lt;sub>3&lt;/sub>O and CHF&lt;sub>2&lt;/sub>O groups to drug candidates often improve their pharmacological properties, especially metabolic stability, membrane permeability and PK profile. Moreover, the unique non-spherical structure of the OCHF&lt;sub>2&lt;/sub> group can provide interesting and beneficial characteristics. Accordingly, new 3rd-generation taxoids, bearing 3-OCF&lt;sub>3&lt;/sub> or 3-OCF&lt;sub>2&lt;/sub>H (and 3-CH&lt;sub>3&lt;/sub> for comparison) at the C2 benzoate moiety, were synthesized and their potencies against drug-sensitive and drug-resistant cancer cell lines examined. In this study, our previous SAR studies on 3rd-generation taxoids were expanded to disclose that CH&lt;sub>3&lt;/sub>, CF&lt;sub>3&lt;/sub>O and CHF&lt;sub>2&lt;/sub>O groups are well tolerated at this positio</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2026-05-04T04:24:53.137Z</modification><creation>2021-02-20T17:39:57Z</creation></dates><accession>S-EPMC7561017</accession><cross_references><pubmed>31911305</pubmed><doi>10.1016/j.bioorg.2019.103523</doi></cross_references></HashMap>